8-KFiling Date: May 4, 2026

Edwards Lifesciences (EW) 8-K: Executive Change, Reg FD Disclosure (May 4, 2026)

ew-20260502

Event Type

Executive ChangeReg FD DisclosureFinancial Statements

Filing overview

Edwards Lifesciences (EW) filed a Form 8-K (Material Event (8-K)) with the SEC on 2026-05-04. Reported items: Item 5.02 Executive Change; Item 7.01 Reg FD Disclosure; Item 9.01 Financial Statements.

More filings from Edwards Lifesciences (EW)

Edwards Lifesciences (EW) 8-K · Aug 28, 2026Executive Change
Edwards Lifesciences (EW) 10-Q · Aug 4, 2026Quarterly Report · ended 2026-06-30 · Rev $1.7B, NI $241.9M
Edwards Lifesciences (EW) 8-K · Jul 23, 2026Earnings Release; Financial Statements
Edwards Lifesciences (EW) 8-K · May 8, 2026
Edwards Lifesciences (EW) 10-Q · May 6, 2026
Edwards Lifesciences (EW) 8-K · Apr 23, 2026

Recent 8-K filings from other companies

International Paper (IP) 8-K · Oct 8, 2026Financial Statements
Citizens Financial (CFG) 8-K · Oct 8, 2026Bylaw Amendment; Financial Statements
Amex (AXP) 8-K · Oct 8, 2026Reg FD Disclosure
Redwire (RDW) 8-K/A · Oct 8, 2026Shareholder Vote
Super Micro Computer (SMCI) 8-K · Oct 8, 2026Ex-Intel CTO joins board